1Takeda A, Shimada H,Imaseki H,et al. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients:correlation with clinieopathological factors and tumor markers[J]. Oncol Rep,2000,7(2):333-338.
2Karayiannakis AJ, Syrigos KN, Polychronidis A, et al. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery[J].Ann Surg, 2002,236 (1) : 37- 42.
3Mesiano S, Ferrara N, Jafe RB. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites form ation by immunoneutralization[J]. Am J Pathol, 1998,153(4) ; 1249- 1256.
4Shibuya M, Luo JC, Toyoda M, et al. Involvement of VEGF and its receptors in ascites tumor formation [J]. Cancer Chemother Pharmacol, 1999,43(Suppl) :S72-77.
5Nascimento I,Schaer R, Lemaire D, et al. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites[J]. APMIS, 2004,112 (9) 585-587.
7Catarino RM, Lopes JD, Forones NM, et al. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis [J]. Braz J Med Biol Res, 2005,38 (2):271-276.
8Katayama M, Kamihagi K, Hirai S, et al. Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction[J]. Br J Cancer, 1992,65 (4) : 509-514.
1Maquoi E;FrankenneF;BaramovaE.Membrane type 1 matrix metalloproteinase- associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines[J],2000(15).
2Garbett EA;ReedMW;BrownNJ.Proteolysis in human breast and colorectal cancer,1999(02).
3Schwingshackl A;Duszyk M;Brown N.Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha[J],1999(05).
4Michael M;Babic B;Khokha R.Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer[J],1999(06).
5Ohtani H;Tabata N;Nagura H.Immunoelectron microscopic localization of gelatinase A in human gastrointestinal and skin carcinomas:difference between cancer cells and fibroblasts,1995(03).
6Tokumaru Y;Fujii M;Otani Y.Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma:studies of clinical sarples and in vitro cell lines co-cultured with fibroblasts,2000(01).
7Liotta L.Isolaton of a protein that stimulates blood vessel growth[J],1985(6041).
8Powell WC;Knox JD;Navre M.Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice,1993(02).
9Hofmann UB;Westphal JR;Van Kraats AA.Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2(MMP-2) in human melanoma cells in vitro and in vivo[J],2000(01).
10Imren S;Kohn DB;Shimada H.Overexpression of tissue inhibitor of metalloproteinases-2 retrovirl-mediated gene transfer in vivo inhibits tumor growth and invasion,1996(13).
